Peter R. E. Johnson

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results

G. Morgan, W. Gregory, M. Drayson, 2012, Haematologica.

A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.

D. Dunlop, Ranjit V Thomas, Peter R. E. Johnson, 2003, Haematologica.

Poor performance of galactomannan and mannan sandwich enzyme‐linked immunosorbent assays in the diagnosis of invasive fungal infection

M. Copland, T. Holyoake, E. Allan, 2005, British journal of haematology.

From bench to bedside: a case of rapid reversal of bortezomib-induced neuropathic pain by the TRPM8 activator, menthol.

M. Fallon, S. Fleetwood-Walker, Peter R. E. Johnson, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The clinical outcome and toxicity of high‐dose chemotherapy and autologous stem cell transplantation in patients with myeloma or amyloid and severe renal impairment: a British society of blood and marrow transplantation study

C. Fegan, J. Byrne, J. Snowden, 2006, British journal of haematology.

Molecular MRD status and outcome after transplantation in NPM1 mutated AML: results from the UK NCRI AML17 study.

N. Potter, C. Craddock, R. Hills, 2019, Blood.

Spontaneous clinical regression in chronic lymphocytic leukaemia

D. Catovsky, P. Shepherd, I. Ribeiro, 2002, British journal of haematology.

Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.

B. Leber, T. A. Lister, J. Fitzgibbon, 2008, Blood.

THE ROLE OF GRANULOCYTE‐ AND GRANULOCYTE‐MACROPHAGE‐COLONY‐STIMULATING FACTORS IN THE TREATMENT OF ACUTE MYELOID LEUKAEMIA

J. A. Liu Yin, Peter R. E. Johnson, P. Johnson, 1997, British journal of haematology.

platelet disorder with propensity to myeloid malignancy Five new pedigrees with inherited RUNX1 mutations causing familial

B. Leber, T. A. Lister, M. Poon, 2013 .

Safety and efficacy of apixaban for routine thromboprophylaxis in myeloma patients treated with thalidomide‐ and lenalidomide‐containing regimens

A. Mathur, P. Roddie, N. Storrar, 2019, British journal of haematology.

Effectiveness of Clofarabine in Elderly AML Patients with Adverse Cytogenetics Unfit for Intensive Chemotherapy.

M. Baccarani, R. Hills, N. Russell, 2006 .